Licensed medicines, off-label use or evidence-based. Which is most important?

Maurizio Bonati, Evelyne Jacqz-Aigrain, Imti Choonara

Research output: Contribution to journalArticle

10 Citations (Scopus)
Original languageEnglish
JournalArchives of Disease in Childhood
DOIs
Publication statusAccepted/In press - Aug 17 2016

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

Licensed medicines, off-label use or evidence-based. Which is most important? / Bonati, Maurizio; Jacqz-Aigrain, Evelyne; Choonara, Imti.

In: Archives of Disease in Childhood, 17.08.2016.

Research output: Contribution to journalArticle

@article{836fab59b38a404da5be792b0e5f2094,
title = "Licensed medicines, off-label use or evidence-based. Which is most important?",
author = "Maurizio Bonati and Evelyne Jacqz-Aigrain and Imti Choonara",
year = "2016",
month = "8",
day = "17",
doi = "10.1136/archdischild-2016-311527",
language = "English",
journal = "Archives of Disease in Childhood",
issn = "0003-9888",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Licensed medicines, off-label use or evidence-based. Which is most important?

AU - Bonati, Maurizio

AU - Jacqz-Aigrain, Evelyne

AU - Choonara, Imti

PY - 2016/8/17

Y1 - 2016/8/17

UR - http://www.scopus.com/inward/record.url?scp=84983551560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983551560&partnerID=8YFLogxK

U2 - 10.1136/archdischild-2016-311527

DO - 10.1136/archdischild-2016-311527

M3 - Article

JO - Archives of Disease in Childhood

JF - Archives of Disease in Childhood

SN - 0003-9888

ER -